Research map: Therapeutic Assessment of Topical Pirfenidone in a Murine Model of Imiquimod-induced Psoriasis

Back to the article

Papers in this map

  1. Psoriasis Pathogenesis and Treatment · Adriana Rendón · 2019 · 2093 citations · Cited by this paper
  2. A Nasal Gel Formulation of Ubrogepant Nanoparticles for Enhanced and Rapid Brain Delivery in the Treatment of Migraine · 2025 · Related
  3. Immunology of Psoriasis · Michelle Anne Lowes · 2014 · 1671 citations · Cited by this paper
  4. Cardiotoxicity Induced by Doxorubicin: Exploring Research Frontiers, Co-word Analysis, Trends, and Thematic Development · 2026 · Related
  5. Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease · Saleela M. Ruwanpura · 2020 · 342 citations · Cited by this paper
  6. Comparative Evaluation of Peyton’s Four-step Approach and Conventional Teaching Methods for Injection Techniques: A Prospective, Interventional Crossover Study · 2026 · Related
  7. Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints · Marie‐Astrid Boutet · 2018 · 225 citations · Cited by this paper
  8. Partial Purification and Characterizations of Bacteriocin from Lactobacillus casei Isolated from Goat Milk: A Novel Antimicrobial Agent · 2025 · Related
  9. Advanced Characterization of Imiquimod-Induced Psoriasis-Like Mouse Model · Mehwish Jabeen · 2020 · 186 citations · Cited by this paper
  10. Clinical Frontiers of Exosome Research: A Comprehensive Analysis of Human Trials in Diagnostics, Therapeutics, and Regenerative Medicine · 2025 · Related
  11. Pirfenidone: an anti-fibrotic therapy for progressive kidney disease · Monique E. Cho · 2010 · 110 citations · Cited by this paper
  12. Medication Adherence Challenges : Factors Influencing Non-Adherence in Saudi Arabia · 2026 · Related
  13. The Role of IL-17 Cytokines in Psoriasis · Megan Mosca · 2021 · 106 citations · Cited by this paper
  14. Computational Screening of Bioactive Compounds of Gymnema sylvestre for ALR2 Inhibition: A Virtual Screening Approach · 2025 · Related
  15. Molecular and clinical effects of selective tyrosine kinase 2 inhibition with deucravacitinib in psoriasis · Ian M. Catlett · 2021 · 79 citations · Cited by this paper
  16. Sociodemographic Factors and Medication Use Among Pulmonary Hypertension Patients at Teaching Hospital Jakarta · 2025 · Related
  17. Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist · Qingran Li · 2021 · 65 citations · Cited by this paper
  18. Diabetes Mellitus-related Pathogeny: A Precipitating Factor for Alzheimer’s Disease—An Insight on Repurposing Diabetes Pharmacological Treatments in Alzheimer’s Disease · 2025 · Related
  19. Pathological Role of Interleukin-6 in Psoriatic Arthritis · Atsushi Ogata · 2012 · 40 citations · Cited by this paper
  20. Efgartigimod in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Short Communication · 2026 · Related
  21. The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation · H. Salman · 2024 · 38 citations · Cited by this paper
  22. New and Emerging Oral/Topical Small-Molecule Treatments for Psoriasis · Elena Carmona‐Rocha · 2024 · 36 citations · Cited by this paper
  23. Ameliorative effects of topical ramelteon on imiquimod-induced psoriasiform inflammation in mice · Ahmed Wahhab Mohammed Khafaji · 2024 · 36 citations · Cited by this paper
  24. Vildagliptin topical ointment: an effective treatment for imiquimod-induced psoriasis in mice · Basma Farooq Ali · 2025 · 35 citations · Cited by this paper
  25. The ameliorative effects of topical gemifloxacin alone or in combination with clobetasol propionate on imiquimod-induced model of psoriasis in mice · H. Salman · 2023 · 34 citations · Cited by this paper
  26. Mitigative Effects of Topical Norfloxacin on an Imiquimod-Induced Murine Model of Psoriasis · H. Salman · 2024 · 34 citations · Cited by this paper
  27. Suppressive effect of topical moxifloxacin on imiquimod-induced model of psoriasis in mice · Alaa Hamza Abbas · 2025 · 34 citations · Cited by this paper
  28. Mechanisms of psoriasis · Frank Oliver Nestle · 2004 · 22 citations · Cited by this paper
  29. Nintedanib ameliorates imiquimod-induced psoriasis in mice by inhibiting NF-κB and VEGFR2 signaling · Xiaohe Li · 2021 · 18 citations · Cited by this paper
  30. Novel Small-Molecule Treatment and Emerging Biological Therapy for Psoriasis · Yuanyuan Li · 2025 · 18 citations · Cited by this paper
  31. Effects of topical isoxsuprine ointment on imiquimod-induced psoriasiform skin inflammation in mice · Ahmed Wahhab Mohammed Khafaji · 2024 · 13 citations · Cited by this paper
  32. Improvement of psoriatic skin lesions following pirfenidone use in patients with fibrotic lung disease · Τheodoros Karampitsakos · 2023 · 4 citations · Cited by this paper
  33. A Novel HDAC6 Inhibitor Ameliorates Imiquimod-Induced Psoriasis-Like Inflammation in Mice · Anqi Cao · 2025 · 4 citations · Cited by this paper
  34. A Topical Chinese Herbal Alleviates Psoriasis by Regulating Keratinocytes Pyroptosis Through Inhibition of NLRP3 Inflammasome Activation · Xuewan Wang · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)